Pharmaceutical Excipients and Drug Metabolism: A Mini-Review
被引:50
|
作者:
Patel, Rahul
论文数: 0引用数: 0
h-index: 0
机构:
Kingston Univ, Sch Life Sci Pharm & Chem, Drug Discovery Delivery & Patient Care DDDPC, Kingston Upon Thames KT1 2EE, Surrey, EnglandKingston Univ, Sch Life Sci Pharm & Chem, Drug Discovery Delivery & Patient Care DDDPC, Kingston Upon Thames KT1 2EE, Surrey, England
Patel, Rahul
[1
]
Barker, James
论文数: 0引用数: 0
h-index: 0
机构:
Kingston Univ, Sch Life Sci Pharm & Chem, Drug Discovery Delivery & Patient Care DDDPC, Kingston Upon Thames KT1 2EE, Surrey, EnglandKingston Univ, Sch Life Sci Pharm & Chem, Drug Discovery Delivery & Patient Care DDDPC, Kingston Upon Thames KT1 2EE, Surrey, England
Barker, James
[1
]
论文数: 引用数:
h-index:
机构:
ElShaer, Amr
[1
]
机构:
[1] Kingston Univ, Sch Life Sci Pharm & Chem, Drug Discovery Delivery & Patient Care DDDPC, Kingston Upon Thames KT1 2EE, Surrey, England
Conclusions from previously reported articles have revealed that many commonly used pharmaceutical excipients, known to be pharmacologically inert, show effects on drug transporters and/or metabolic enzymes. Thus, the pharmacokinetics (absorption, distribution, metabolism and elimination) of active pharmaceutical ingredients are possibly altered because of their transport and metabolism modulation from the incorporated excipients. The aim of this review is to present studies on the interaction of various commonly-used excipients on pre-systemic metabolism by CYP450 enzymes. Excipients such as surfactants, polymers, fatty acids and solvents are discussed. Based on all the reported outcomes, the most potent inhibitors were found to be surfactants and the least effective were organic solvents. However, there are many factors that can influence the inhibition of CYP450, for instance type of excipient, concentration of excipient, type of CYP450 isoenzyme, incubation condition, etc. Such evidence will be very useful in dosage form design, so that the right formulation can be designed to maximize drug bioavailability, especially for poorly bioavailable drugs.
机构:
Grigore T Popa Univ Med & Pharm, Fac Med, Iasi 700115, RomaniaGrigore T Popa Univ Med & Pharm, Fac Med, Iasi 700115, Romania
Luca, Alina-Costina
Ciobica, Alin
论文数: 0引用数: 0
h-index: 0
机构:
Alexandru Ioan Cuza Univ, Dept Res, Fac Biol, Iasi 700505, RomaniaGrigore T Popa Univ Med & Pharm, Fac Med, Iasi 700115, Romania
Ciobica, Alin
Bild, Walther
论文数: 0引用数: 0
h-index: 0
机构:
Grigore T Popa Univ Med & Pharm, Fac Med, Iasi 700115, Romania
Romanian Acad, Ctr Biomed Res, Iasi 700481, RomaniaGrigore T Popa Univ Med & Pharm, Fac Med, Iasi 700115, Romania
Bild, Walther
论文数: 引用数:
h-index:
机构:
Curpan, Alexandrina-Stefania
Braha, Elena Emanuela
论文数: 0引用数: 0
h-index: 0
机构:
CI Parhon Natl Inst Endocrinol, Bucharest 011863, RomaniaGrigore T Popa Univ Med & Pharm, Fac Med, Iasi 700115, Romania
机构:
Southwest Med Univ, Inst Canc Med, Luzhou, Peoples R China
Southwest Med Univ, Sch Basic Med Sci, Luzhou, Peoples R ChinaSouthwest Med Univ, Inst Canc Med, Luzhou, Peoples R China
Wang, Wenjun
Zeng, Fancai
论文数: 0引用数: 0
h-index: 0
机构:
Southwest Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Luzhou, Peoples R ChinaSouthwest Med Univ, Inst Canc Med, Luzhou, Peoples R China
Zeng, Fancai
Hu, Yingying
论文数: 0引用数: 0
h-index: 0
机构:
Southwest Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Luzhou, Peoples R ChinaSouthwest Med Univ, Inst Canc Med, Luzhou, Peoples R China
Hu, Yingying
Li, Xiang
论文数: 0引用数: 0
h-index: 0
机构:
Southwest Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Luzhou, Peoples R ChinaSouthwest Med Univ, Inst Canc Med, Luzhou, Peoples R China